RCKT
Rocket Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.86
+1.85%Leverage
- Debt / equity
- 0.07x
- Net debt / equity
- -0.54x
- Debt / assets
- 0.06x
- Debt / EBITDA
- 3.12x
- Net debt / EBITDA
- -25.12x
Liquidity & coverage
- Current ratio
- 9.24x
- Quick ratio
- 9.24x
- Cash ratio
- 9.06x
- Interest coverage
- -40.53x
- EBITDA / interest
- 1.68x
- Working capital
- $258.2M
Cash & dividend
- FCF / debt
- -6.87x
- Cash flow / debt
- -6.87x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026